/
Our Vision Our vision is to accelerate medical innovation to patients through risk-reward-sharing partnerships with leading medical device companies. Our Company We are a biomedical innovation company accelerating high-impact technologies to patients through strategic collaborations with market-leading global medical device companies.
The business is unprofitable at the operating level (-154.73% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue up 1169.2% YoY with margins expanding 2282.8pp.
Negative free cash flow of -$49M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$33M
▲ +1169.2% YoY
Net Income (TTM)
-$55M
▲ +13.6% YoY
Op. Margin
-167.96%
▲ +2282.8pp YoY
ROIC
-84.39%
▲ +16.8pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$55M
▲ +2.7% YoY
Op. Cash Flow (TTM)
-$55M
▲ +3.2% YoY
Net Debt
-$78M
Net Cash Position
Cash & Equiv.
$94M
3Y CAGR: +111.6%
Continue Research